| |
Latest 10 SEC filings (by transaction date) for HRMY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -8,013 | $33.58 |
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -9,644 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -2,335 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Common Stock | S - Open market or private sale | -11,979 | $32.00 |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,979 | $8.22 |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -94 | |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -100 | |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Common Stock | S - Open market or private sale | -194 | $32.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for HRMY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -8,013 | $33.58 |
Apr 2/24 | Mar 29/24 | Kapadia Sandip | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -9,644 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -2,335 | |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Common Stock | S - Open market or private sale | -11,979 | $32.00 |
Mar 18/24 | Mar 15/24 | Dierks Jeffrey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,979 | $8.22 |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -94 | |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 | -100 | |
Mar 11/24 | Mar 8/24 | Dierks Jeffrey | Direct Ownership | Common Stock | S - Open market or private sale | -194 | $32.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |